These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 34513807)

  • 21. Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Current Understanding and Future Perspectives.
    Wu MF; Xu KZ; Guo YG; Yu J; Wu Y; Lin LM
    Cardiovasc Drugs Ther; 2019 Dec; 33(6):739-748. PubMed ID: 31655942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct Cardiac Reprogramming with Engineered miRNA Scaffolds.
    Muniyandi P; Maekawa T; Hanajiri T; Palaninathan V
    Curr Pharm Des; 2020; 26(34):4285-4303. PubMed ID: 32216733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Stem cell therapy for myocardial regeneration: mechanisms and current clinical applications].
    Centola M; Schuleri KH; Lardo AC; Hare JM
    G Ital Cardiol (Rome); 2008 Apr; 9(4):234-50. PubMed ID: 18543793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent review of the effect of nanomaterials on stem cells.
    Zhou X; Yuan L; Wu C; Cheng Chen ; Luo G; Deng J; Mao Z
    RSC Adv; 2018 May; 8(32):17656-17676. PubMed ID: 35542058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining Nanomaterials and Developmental Pathways to Design New Treatments for Cardiac Regeneration: The Pulsing Heart of Advanced Therapies.
    Cassani M; Fernandes S; Vrbsky J; Ergir E; Cavalieri F; Forte G
    Front Bioeng Biotechnol; 2020; 8():323. PubMed ID: 32391340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extrinsically Conductive Nanomaterials for Cardiac Tissue Engineering Applications.
    Ul Haq A; Carotenuto F; Di Nardo P; Francini R; Prosposito P; Pescosolido F; De Matteis F
    Micromachines (Basel); 2021 Jul; 12(8):. PubMed ID: 34442536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic approaches for cardiac regeneration and repair.
    Hashimoto H; Olson EN; Bassel-Duby R
    Nat Rev Cardiol; 2018 Oct; 15(10):585-600. PubMed ID: 29872165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inorganic Nanomaterials for Soft Tissue Repair and Regeneration.
    Urie R; Ghosh D; Ridha I; Rege K
    Annu Rev Biomed Eng; 2018 Jun; 20():353-374. PubMed ID: 29621404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016.
    Yao X; Shah ND; Gersh BJ; Lopez-Jimenez F; Noseworthy PA
    JAMA Netw Open; 2020 Nov; 3(11):e2025505. PubMed ID: 33216139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular cardiomyoplasty and cardiac tissue engineering for myocardial therapy.
    Wang F; Guan J
    Adv Drug Deliv Rev; 2010 Jun; 62(7-8):784-97. PubMed ID: 20214939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of Stem Cell Technologies to Regenerate Injured Myocardium and Improve Cardiac Function.
    Mardanpour P; Nayernia K; Khodayari S; Khodayari H; Molcanyi M; Hescheler J
    Cell Physiol Biochem; 2019; 53(1):101-120. PubMed ID: 31215778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration.
    Liu N; Ye X; Yao B; Zhao M; Wu P; Liu G; Zhuang D; Jiang H; Chen X; He Y; Huang S; Zhu P
    Bioact Mater; 2021 May; 6(5):1388-1401. PubMed ID: 33210031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metal-based nanomaterials and nanocomposites as promising frontier in cancer chemotherapy.
    Kumar S; Shukla MK; Sharma AK; Jayaprakash GK; Tonk RK; Chellappan DK; Singh SK; Dua K; Ahmed F; Bhattacharyya S; Kumar D
    MedComm (2020); 2023 Apr; 4(2):e253. PubMed ID: 37025253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Robust Cardiac Regeneration: Fulfilling the Promise of Cardiac Cell Therapy.
    Selvakumar D; Clayton ZE; Chong JJH
    Clin Ther; 2020 Oct; 42(10):1857-1879. PubMed ID: 32943195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study.
    Kim H; Kim S; Han S; Rane PP; Fox KM; Qian Y; Suh HS
    BMC Public Health; 2019 Aug; 19(1):1112. PubMed ID: 31412823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanomaterials as potential and versatile platform for next generation tissue engineering applications.
    Singla R; Abidi SMS; Dar AI; Acharya A
    J Biomed Mater Res B Appl Biomater; 2019 Oct; 107(7):2433-2449. PubMed ID: 30690870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenges to success in heart failure: Cardiac cell therapies in patients with heart diseases.
    Oh H; Ito H; Sano S
    J Cardiol; 2016 Nov; 68(5):361-367. PubMed ID: 27341741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances of nanotechnology in osteochondral regeneration.
    Deng C; Xu C; Zhou Q; Cheng Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Nov; 11(6):e1576. PubMed ID: 31329375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition.
    Rosenblit PD
    Curr Diab Rep; 2019 Jul; 19(8):61. PubMed ID: 31332544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac regeneration with pluripotent stem cell-derived cardiomyocytes and direct cardiac reprogramming.
    Sadahiro T
    Regen Ther; 2019 Dec; 11():95-100. PubMed ID: 31304202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.